close

Agreements

Date: 2012-03-02

Type of information: Production agreement

Compound: oligonucleotide peptide conjugates

Company: Bachem (Switzerland) BioSpring (Germany)

Therapeutic area:

Type agreement:

R&D
manufacturing
production

Action mechanism:

Disease:

Details:

Bachem and BioSpring have agreed to collaborate on oligonucleotide peptide conjugates for R&D on the manufacture of oligonucleotide-peptide conjugates involved in R&D projects. The required expertise for both oligonucleotide and peptide chemistry are thus brought together for a future collaboration by two manufacturers experienced in their fields.
 


 

Financial terms:

Latest news:

Is general: Yes